Shaanxi Meibang Pharmaceutical Group (605033.SH) terminates the issue of convertible bonds and withdraws the application documents.
Meibang Corporation (605033.SH) issued an announcement about its application to issue convertible corporate bonds to unspecified recipients...
Shaanxi Meibang Pharmaceutical Group (605033.SH) announced that since the company applied to issue convertible corporate bonds to unspecified entities, the company has been actively promoting related work with relevant intermediary institutions. However, after comprehensive consideration of business performance, market conditions, and other factors, and after repeated careful discussions with each intermediary institution, the company has decided to terminate the issuance of convertible corporate bonds to unspecified entities this time.
Related Articles
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
US Stock Market Move | ACCL.US, a company controlled by Zhuo Yuan, has landed on the US stock market with a 1.75% increase in trading at the opening.
US Stock Market Move | NVIDIA Corporation holds Concept Stock Coreweave (CRWV.US), which fell more than 7%.
US Stock Market Move | Reach a $1.085 billion cooperation agreement with domestic and foreign pharmaceutical companies, Rani Therapeutics (RANI.US) soars over 265%.
RECOMMEND
